| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | SVP Clin Dev &Chief Med Ofc | SVP, Clinical Development
1 company
Haumann Brett K serves as a Chief Medical Officer at TBPH. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $4.6M at current prices.
The biggest single holding is TBPH (~$4.6M) as Chief Medical Officer. The recent filings there lean toward selling, a net 53,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2020 | TBPH Theravance Biopharma, Inc. | Chief Medical Officer | Sell | 25,000 | $18.29 | $457,240.00 | -8.1% | |
| Mar 7, 2017 | TBPH Theravance Biopharma, Inc. | SVP Clin Dev &Chief Med Ofc | Sell | 14,000 | $31.50 | $440,974.72 | -7.9% | |
| Aug 25, 2016 | TBPH Theravance Biopharma, Inc. | SVP Clin Dev &Chief Med Ofc | Sell | 4,491 | $27.99 | $125,703.09 | -2.3% | |
| Aug 19, 2016 | TBPH Theravance Biopharma, Inc. | SVP Clin Dev &Chief Med Ofc | Sell | 9,509 | $27.97 | $265,966.73 | -4.6% |